News

Acquisition gives Roche access to antibody-boosting technology - and possible anti-cancer treatments in the pipeline

Once upon a time, there were great businesses with massive central labs that did both product development and basic research. Today, most corporate labs have refocused on applied research. They do not know what they are missing.

Not everyone can produce a Google, Stanford's way of doing business is making other universities look with interest at the revenue possibilities of equity deals.

No, it has nothing to do with government PR. It's an exotic thing that you can do with electrons.